02:48 p.m
Tuesday, February 21, 2023
Biotechnology has announced that it plans to produce a cancer vaccine before 2030, according to Sky News.
Ad space
It is scheduled that “BioNTech” will start conducting clinical trials on the expected vaccine in Britain this year, according to statements made by Ugur Shahir, the company’s co-founder and CEO, the day before yesterday, to the German magazine “Der Spiegel”.
Ad space
Ogur added that the company will rely on mRNA technology to develop a cancer vaccine, similar to its coronavirus vaccines.
Also read: A vaccine that destroys brain cancer
The company official explained: “In 2014, we needed a period ranging between 4 and 6 months to create an individual vaccine for cancer, and now we need 4 to 6 weeks,” continuing: “Our goal is to obtain it in less than a month.”
It is noteworthy that the company “BioNTech” has gained wide popularity at the high level and achieved huge profits after its partnership with “Pfizer” to produce the Covid-19 vaccine.
